Market Overview

Barrington Research Initiates Rosetta Genomics With Outperform


Analysts at Barrington Research initiated coverage on Rosetta Genomics Ltd. (USA) (NASDAQ: ROSG) with a Outperform rating.

The target price for Rosetta Genomics is set to $8.

Rosetta Genomics shares have dropped 15.23 percent over the past 52 weeks, while the S&P 500 index has surged 11.85 percent in the same period.

Rosetta Genomics' shares rose 1.80 percent to $3.40 in pre-market trading.

Latest Ratings for ROSG

Dec 2017Barrington ResearchDowngradesOutperformMarket Perform
Jan 2016Aegis CapitalInitiates Coverage onBuy
Apr 2015Barrington ResearchInitiates Coverage onOutperform

View More Analyst Ratings for ROSG
View the Latest Analyst Ratings


Related Articles (ROSG)

View Comments and Join the Discussion!

Posted-In: Barrington ResearchInitiation Analyst Ratings

Latest Ratings

QEPPiper SandlerDowngrades1.0
CALMStephens & Co.Reiterates55.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at